Clinical TrialID 3716
Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients
NCT03376620
Hypertrophic Scar
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 3716
- Evidence Id
- 3716
- Core Evidence Id
- 3716
- Source Clinical Trial Id
- 3688
- Herb2 Clinical Trial Id
- HBCT003688
- Nct Id
- NCT03376620
- Title
- Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients
- Status
- Completed
- Phase
- Phase 3
- Study Result
- No
- Study Condition
- Hypertrophic Scar
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
- Intervention
- DRUG: 1,4-Diaminobutane|DRUG: 10% Urea cream
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Double
- Intervention Purpose
- Prevention
- Gender
- Female
- Age
- Adult, Older_Adult
- Enrollment
- 56
- Outcome Measure
- Duredness of scar at post treatment time frame for active versus control breast, Surface deformational force in grams of scar tissue in each of the treated breasts, 12 weeks
- Sponsor Collaborator
- University of Manitoba
- Funded By
- OTHER
- Location
- Other Id
- B2008:134
- Start Date
- 2011-09-02
- Primary Completion Date
- 2013-08-13
- Completion Date
- 2016-07-15
- First Posted
- 2017-12-18
- Results First Posted
- Last Update Posted
- 2017-12-20
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT03376620
- Title Cn
- Title En
- Role of Topical Putrescine (Fibrostat) for Prevention of Hypertrophic Scars in Mammoplasty Patients
- Bilingual Status
- semi_complete